Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107816 · ClinicalTrials.gov registry record · NA
A Fruit and Vegetable Prescription Program
A NA study of Diabetes Mellitus and Diabetes Complications, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06107816: Recruiting NA study of Diabetes Mellitus and Diabetes Complications, sponsored by Milton S. Hershey Medical Center.
NCT06107816 is a NA study of Diabetes Mellitus and Diabetes Complications that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 120 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06107816, a NA study of Diabetes Mellitus and Diabetes Complications, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V prescription (F\&V Rx) programs are embedded into clinical settings and provide patients with vouchers to purchase F\&V at local retailers. The proposed study aims to test the effects of a F\&V Rx on diabetes self-management education and support (DSME/S) uptake and retention, dietary intake of F\&V and diet quality, glucose control (hemoglobin A1c), and program implementation outcomes.
Primary Outcome
Defined as the number of participants who attend any 1 DSME (# attend any 1 DSME/S session/total # randomized)
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL F&V Rx alone
- BEHAVIORAL F&V Rx plus DSME/S
Study Locations (1)
Pennsylvania
- Penn State Health St. Joseph Downtown Campus - Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-07-26 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT06107816 shows while recruiting
NCT06107816 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT06107816 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06107816 about?
NCT06107816 is a clinical study titled "A Fruit and Vegetable Prescription Program". Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V prescription (F\&V Rx) programs are embedded into clinical settings and provide patients with vouch...
What is the current status of trial NCT06107816?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-07-26. Estimated completion is 2027-07.
What conditions does trial NCT06107816 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Diabetes Complications.
What interventions are being tested in trial NCT06107816?
The interventions under investigation include: Usual Care (BEHAVIORAL), F&V Rx alone (BEHAVIORAL), F&V Rx plus DSME/S (BEHAVIORAL).
Who is sponsoring clinical trial NCT06107816?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06107816 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06107816's enrollment target sits among peer trials
120 111th of 208 higher than 96 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI